联邦贸易委员会调查制药行业的做法,而各州则力促制定法律,以管制PBM和降低药物成本。 FTC investigates pharmaceutical industry practices, while states push for laws to regulate PBMs and lower drug costs.

公平贸易委员会正在密切审查制药业的反竞争做法,重点是捆绑折扣、药店福利管理人员的作用以及兼并对创新和竞争的潜在危害等问题。 The FTC is closely examining anticompetitive practices in the pharmaceutical industry, focusing on issues like bundled rebates, the role of pharmacy benefit managers (PBMs), and potential harm to innovation and competition from mergers. 与此同时,阿拉巴马州的新法将管制私营银行,以确保公平支付,39个州正在倡导制定联邦立法,禁止拥有药店的私营银行,认为这将增加竞争和降低药物成本。 Meanwhile, Alabama's new law will regulate PBMs to ensure fair payments, and 39 states are advocating for federal legislation to ban PBMs from owning pharmacies, arguing it would increase competition and lower drug costs. 俄勒冈州提出的法案旨在解决药店关闭问题, 给予药店更多对抗PBM的影响力。 Oregon's proposed bill seeks to address pharmacy closures by giving pharmacies more leverage against PBMs.